Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Feb 7;16(5):554-62.
doi: 10.3748/wjg.v16.i5.554.

Hepatitis D: Scenario in the Asia-Pacific region

Zaigham Abbas  1 , Wasim Jafri, Sajjad Raza
Affiliations
Review

Hepatitis D: Scenario in the Asia-Pacific region

Zaigham Abbas et al. World J Gastroenterol. .

Abstract

Hepatitis D virus (HDV) infection is present worldwide and affects all age groups. Around 18 million people are estimated to be infected with HDV. An important trend in HDV infection is global decline. HDV prevalence has decreased significantly in Europe since the 1970s and 1980s when it was first reported. The Asia-Pacific region now seems to be where HDV is a major health concern. There is a lack of available data from most of the countries from this region; hence, the true status of HDV cannot be determined. In South Asia, most of the countries have conditions that are favorable for the spread of hepatitis B and other related infections. Countries like Pakistan and Iran have shown an increase in HDV prevalence over a period of time. Other countries and region like China, Turkey, Australia, Japan, India and Taiwan, some of which had very high HDV prevalence in the past, have shown a decline in the incidence, but high prevalence persists in some. Intravenous drug abusers, homosexual men and women, prostitutes, and people on hemodialysis are the groups with very high HDV prevalence.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Hepatitis D prevalence in the Asia-Pacific region.
See this image and copyright information in PMC

References

    1. World Health Organization. Hepatitis Delta [WHO/CDS/CSR/NCS/2001.1] Available from: http://www.searo.who.int/EN/Section10/Section1027_9489.htm.
    1. Fonseca JC. [Hepatitis D] Rev Soc Bras Med Trop. 2002;35:181–190. - PubMed
    1. Rizzetto M. Hepatitis D: the comeback? Liver Int. 2009;29 Suppl 1:140–142. - PubMed
    1. Koytak ES, Yurdaydin C, Glenn JS. Hepatitis d. Curr Treat Options Gastroenterol. 2007;10:456–463. - PubMed
    1. Moatter T, Abbas Z, Shabir S, Jafri W. Clinical presentation and genotype of hepatitis delta in Karachi. World J Gastroenterol. 2007;13:2604–2607. - PMC - PubMed